Over the last few years, it has been well acknowledged that the levels of CXCL12 in human and mouse tissues were higher in the preferable sites of metastasis for prostate cancer cells (e.g., bone, liver, and kidney), compared with that in tissues rarely affected (e.g., lung, tongue, and eye) [43]. This evidence concerns the gene CXCL12 and prostate cancer.